Fluconazole Is Neuroprotective via Interactions with the IGF-1 Receptor.
Ontology highlight
ABSTRACT: There is a continuing unmet medical need to develop neuroprotective strategies to treat neurodegenerative disorders. To address this need, we screened over 2000 compounds for potential neuroprotective activity in a model of oxidative stress and found that numerous antifungal agents were neuroprotective. Of the identified compounds, fluconazole was further characterized. Fluconazole was able to prevent neurite retraction and cell death in in vitro and in vivo models of toxicity. Fluconazole protected neurons in a concentration-dependent manner and exhibited efficacy against several toxic agents, including 3-nitropropionic acid, N-methyl D-aspartate, 6-hydroxydopamine, and the HIV proteins Tat and gp120. In vivo studies indicated that systemically administered fluconazole was neuroprotective
SUBMITTER: Toodle V
PROVIDER: S-EPMC9587198 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA